GOBA Active for Pets: Veterinary Product Profile

GOBA Active for Pets is a named branded product for Dogs and cats; manufacturer positioning is kept separate from independent clinical and regulatory evidence.

50 g oral powder described as a complementary feed. Intended species: Dogs and cats.

The current official page lists a proprietary mixture of Cordyceps, described as Caterpillar fungus, and wholemeal starch. It does not publicly provide the species split, extract ratio, amount of Cordyceps per unit, or detailed analytical constituents. The page identifies organic production under SI-EKO-001.

GOBA positions Active for Pets for endurance, energy, recovery, vitality, and general condition in dogs and cats. The current manufacturer page is not primarily a cancer product page. Any source-table characterization as an oncology competitor must therefore be narrowed to a general mushroom-based support product, not repeated as a tumour-treatment claim.

May be discussed only as supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Define a modest supportive objective, baseline, review date, adverse-event plan, and stopping rule with the veterinarian.

Bring the current label, lot, full ingredient panel, country version, complete diet, medicines, and supplements to the treating veterinarian.

The manufacturer page verifies a current veterinary/pet product, brand, powder form, pack size, broad ingredients, and intended species. No product-specific canine or feline oncology trial was identified, and the public quantitative formula is incomplete. Cordyceps research involving other species, extracts, people, or experimental systems cannot demonstrate a clinical outcome for this blend.

The proprietary composition limits exposure and interaction assessment. Review mushroom or cereal allergy, gastrointestinal tolerance, diabetes, autoimmune disease, immunosuppressive therapy, anticoagulants, surgery, pregnancy, and concurrent mushroom supplements. Organic certification does not establish absence of all contaminants or suitability with medicines; lot testing and the current label remain relevant.

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

Marketed from Slovenia as a complementary feed for pets under the manufacturer's current official channel. No Slovenian or EU veterinary-medicine authorisation for cancer treatment was identified. Organic certification SI-EKO-001 concerns production status and does not establish veterinary anticancer efficacy.

Slovenia; European Union

Record pack, lot, expiry, full label, diet, concurrent supplements, and the modest goal being evaluated, such as routine acceptance or activity. Track appetite, vomiting, stool, itching, swelling, energy, weight, and prescribed-treatment adherence. If an oncology patient uses it, tumour assessment and treatment monitoring continue without altered intervals.